Vertex Pharmaceuticals (VRTX) Enterprise Value (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.66% |
| Dec 31, 2025 | -5.11% |
| Sep 30, 2025 | 1.50% |
| Jun 30, 2025 | -2.93% |
| Mar 31, 2025 | -1.39% |
| Dec 31, 2024 | 6.26% |
| Sep 30, 2024 | -12.58% |
| Jun 30, 2024 | 43.02% |
| Mar 31, 2024 | 9.33% |
| Dec 31, 2023 | 5.95% |
| Sep 30, 2023 | -6.16% |
| Jun 30, 2023 | -7.90% |
| Mar 31, 2023 | 3.38% |
| Dec 31, 2022 | -10.31% |
| Sep 30, 2022 | -5.59% |
| Jun 30, 2022 | -12.32% |
| Mar 31, 2022 | -9.48% |
| Dec 31, 2021 | -8.10% |
| Sep 30, 2021 | -3.77% |
| Jun 30, 2021 | 3.12% |
| Mar 31, 2021 | -3.98% |
| Dec 31, 2020 | -8.26% |
| Sep 30, 2020 | -12.85% |
| Jun 30, 2020 | -30.08% |
| Mar 31, 2020 | -10.03% |
| Dec 31, 2019 | 4.71% |
| Sep 30, 2019 | -1.14% |
| Jun 30, 2019 | -13.61% |
| Mar 31, 2019 | -9.78% |
| Dec 31, 2018 | -4.65% |
| Sep 30, 2018 | -10.53% |
| Jun 30, 2018 | -11.93% |
| Mar 31, 2018 | -17.94% |
| Dec 31, 2017 | -15.27% |
| Sep 30, 2017 | -22.23% |
| Jun 30, 2017 | -451.81% |
| Mar 31, 2017 | 78.70% |
| Dec 31, 2016 | -33.06% |
| Sep 30, 2016 | -6.53% |
| Jun 30, 2016 | -2.01% |
| Mar 31, 2016 | 2.51% |
| Dec 31, 2015 | -4.41% |
| Sep 30, 2015 | 1.38% |
| Jun 30, 2015 | 25.59% |
| Mar 31, 2015 | 15.07% |
| Dec 31, 2014 | 7.57% |
| Sep 30, 2014 | -21.21% |
| Jun 30, 2014 | 7.93% |
| Mar 31, 2014 | 9.62% |
| Dec 31, 2013 | -18.11% |
| Sep 30, 2013 | 10.85% |
| Jun 30, 2013 | -32.84% |
| Mar 31, 2013 | 6.85% |
| Dec 31, 2012 | 10.77% |
| Sep 30, 2012 | -6.31% |
| Jun 30, 2012 | -4.95% |
| Mar 31, 2012 | -36.53% |
| Dec 31, 2011 | -51.99% |
| Mar 31, 2011 | 20.16% |
| Dec 31, 2010 | 14.26% |
| Sep 30, 2010 | -22.86% |
| Jun 30, 2010 | 10.39% |
| Mar 31, 2010 | 14.96% |
| Dec 31, 2009 | -129.80% |
| Sep 30, 2009 | -36.72% |
| Jun 30, 2009 | 32.09% |